America’s Frontline Doctors on Covid-19 Vaccination Concerns By Mrs Vera West

America’s Frontline Doctors have put to gather a readable paper on concerns about the Covid-19 vaccines. First the executive summary then some key extracts, for your consultation.

https://www.americasfrontlinedoctors.com/

“This document represents the preliminary findings of an investigation conducted by the member-physicians of America's Frontline Doctors. We are recommending caution for patients and policy makers and employers. Additional transparency and more research are needed before we ask Americans to embark on the largest experimental medical program in US history. The unknowns must be addressed through a scientifically rigorous process. Mandates for experimental medical therapies are neither permissible nor advisable. Ordinary Americans should not be compelled to sign up for a "vaccine passport" or similar mandate just to travel on an airplane or see a concert with friends. The potential for third-party abuse of private health information and real medical risk to individuals remains much too high. Concentrations of private power pose a threat to privacy and other civil liberties and policy makers must proceed with caution. We also ask our public health agencies to avoid prioritization of experimental biological agents based on race. Zero-pressure “opt-out” policies should be continued with the COVID-19 vaccine just as they have with previous inoculations. Furthermore, the CDC's tiers of prioritization place seniors not residing in long-term-care facilities last in line for immunization, even though patient experience and data tell us that 70 percent of US deaths have occurred among those 70 and older.

What does AFLDS mean by “experimental vaccine”? According to the Food and Drug Administration, “An investigational drug can also be called an experimental drug and is being studied to see if your disease or medical condition improves while taking it.” See pg. 15. The Pfizer and Moderna and AstraZeneca applications properly identify their new agents as “investigational,” which is normal at this very early stage of development. All the vaccine candidates are categorized as experimental for the following four reasons: • the pharmaceutical companies have applied for investigational use status • adverse events will be settled under the legal standard for experimental medications • recipients are enrolled as subjects in a medical trial to gather data on side effects. • persons are enrolled in a pharmaco-vigilance tracking system for at least two years • many groups of persons have not been studied at all, including: prior COVID-19 patients, pregnant women, youths, elderly • no published animal studies data Is the vaccine safe? Vaccine safety requires proper animal trials and peer-reviewed data, neither of which has occurred during operation warp speed. This is especially concerning considering the fatal failure of prior coronavirus vaccine attempts such as SARS-CoV-1, the virus that is 78% identical to SARS-CoV-2 (COVID-19). Prior coronavirus (and other respiratory) vaccines have failed due to the scientific phenomena known as pathogenic priming that makes the vaccine recipient more likely to suffer a sudden fatal outcome due to massive cytokine storm when exposed to the wild virus. In addition to pathogenic priming there are three other potential safety issues that are being minimized. While we are hopeful that the vaccine is both effective and safe, hope is not science. Because these experimental vaccines have not been tested in accordance with the usual standards, we have serious concerns about safety.”

So, what are these concerns? The following:

“Safety Concerns Regarding the Experimental COVID-19 Vaccines 1. Brand New Technology. No vaccine based on messenger RNA has ever been approved for any disease, or even entered final-stage trials until now, so there’s no peer-reviewed published human data to compare how mRNA stacks up against older technologies.24 How well mRNA vaccines will actually prevent COVID-19 remains unknown. This new technology is less stable than older technologies, for example, requiring deep freezing temperatures up to negative 70 degrees Celsius for Pfizer’s vaccine. This differs from other vaccines that are typically kept in ordinary refrigerators. Recently a vaccine candidate had to be halted because test 23 https://www.sciencemag.org/news/2019/04/dengue-vaccine-fiasco-leads-criminal-charges-researcherphilippines 24 https://www.bloomberg.com/features/2020-moderna-biontech-COVID-shot/ August 11, 2020 14 subjects has ‘false positive’ HIV test results – in other words, unexpected things must be expected with brand new experimental technology.25 2. Failure of Previous Coronavirus Vaccines. Despite trying for decades, scientists have never been able to create a successful coronavirus vaccine. Whenever they think they have, the experimental coronavirus vaccine has failed and animals who got the experimental vaccine died.26 3. No Independently Published Animal Studies. Most other previous vaccines have performed and published results on animal studies prior to giving to humans. This is critical because deadly effects are often not seen until this step. Vaccines that have been given to humans prior to animal trials have frequently resulted in deaths that caused the governments to yank the vaccines. Most scientists believe that human death is inevitable if there are no prior peer-reviewed animal studies.27 4. Known Complications. One of the known complications of vaccines is something called immune enhancement. One type of immune enhancement is known as Antibody Dependent Enhancement (ADE). This is a process where a virus leverages antibodies to aid infection. In short, the antiCOVID antibodies, stimulated by a vaccine, amplify the infection rather than prevent its damage. This paradoxical reaction has been seen repeatedly in other vaccines and animal development trials especially with coronavirus vaccine trials.28 Other known complications of vaccines include neurological diseases such as transverse myelitis, Bells’ Palsy multiple sclerosis, autism, and Guillain-Barre. For example, in 1976 the government attempted a mass vaccination of the population with a newly created Swine Flu vaccine. The vaccination program was aborted after about 450 people came down with Guillain-Barre. The extremely limited COVID-19 vaccine data already has at least two transverse myelitis cases 29 and four Bell’s Palsy cases that may be linked to vaccination.. 25 https://www.cnn.com/2020/12/10/australia/australia-vaccine-hiv-intl-hnk/index.html 26 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335060/ 27 https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-datapreclinical-studies-mrna We learn about these studies only from the company itself. 28 https://academic.oup.com/jid/article/222/12/1946/5891764 29 https://www.nature.com/articles/d41586-020-02706-6 15 5. Unknown Complications. There are entire populations for whom we don’t know the data. For example, we have no knowledge of the immune response in vaccinated individuals who later contract the disease, and we also do not know the effects on disease course in vaccinated individuals with waning immunity. We do not know the effects on the elderly. We do not know the effect on the pregnant or soon to be pregnant. There is no actual data at all for an enormous percentage of the population, probably more than half. Just by the mere fact that these trials were launched within the past six months, we cannot know of any long-term effects or interactions with other viruses such as influenza or the seasonal cold, especially considering that two of the vaccines nearest to public distribution take an entirely novel approach with mRNA. The mechanism of action of the experimental mRNA vaccines includes a possible autoimmune rejection of the placenta. In layman’s terms, the vaccine may permanently interfere with a woman’s ability to maintain a pregnancy. The vaccine companies themselves acknowledge the possibility of ill effects on a pregnancy on the vaccine bottle, which says the following: “it is unknown whether COVID-19 mRNA VaccineBNT162b2 has an impact on fertility. And women of childbearing age are advised to avoid pregnancy for at least two months after their second dose.”30 6. Pharmaceuticals are Immune from All Liability. The same companies (and executives) that profit from this vaccine are immune from all liability. In 1986, Congress passed the National Childhood Vaccine Injury Act (NCVIA). It provides immunity from liability to all vaccine manufacturing companies. With COVID-19 experimental vaccine, AstraZeneca goes even further in acknowledging that this is an emergency situation and requested no liability from the EU. “This is a unique situation 30https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9414 52/Information_for_healthcare_professionals.pdf 16 where we as a company simply cannot take the risk if in ... four years the vaccine is showing side effects,” Ruud Dobber, a member of Astra’s senior executive team, told Reuters.31 7. An Experimental Vaccine Is Not Safer Than a Very Low IFR. The IFR was always known to be very low for the young and healthy middle aged, and it has now been shown to be extraordinarily low. We are getting better and better at treating COVID-19: the death rate in terms of population continues to fall, hospital stays for COVID-19 get shorter and hospital mortality from COVID-19 plummets. Questions Regarding the Effectiveness of the COVID-19 Experimental Vaccines 1. No Proof the Vaccine Stops Transmission of the Virus. The trial data on the vaccinations released so far has not addressed the issue of transmission of the virus. That is, the efficacy data is primarily based on symptoms, not on transmission. Could the vaccine create asymptomatic carriers that can unknowingly transmit the virus? The scientists are very upfront about the fact that they don’t know if the vaccine even stops the spread of the virus!32 Dr. Corey who oversees the vaccine trials for the NIH COVID-10 Prevention Network says: “the studies aren’t designed to assess transmission. They don’t ask that question and there’s really no information on this at this point in time.” 2. Unknown Mortality or Hospital Admission Benefit. Currently the pharmaceutical companies believe that their first COVID-19 vaccines are ~95% effective. Pharmaceutical companies typically believe their vaccinations are more effective than they actually are. For example, CDC data show that the influenza vaccine 31 https://www.reuters.com/article/us-astrazeneca-results-vaccine-liability/astrazeneca-to-be-exemptfrom-coronavirus-vaccine-liability-claims-in-most-countries-idUSKCN24V2EN 32 https://www.medscape.com/viewarticle/941388 17 was 38% effective in 2017-18, 20% in 2018-19, and 39% in 2019-20 even though its efficacy was expected to be much higher when it was first introduced in 1938. Even if the COVID-19 vaccine is really 95% effective in the real world, the survival rate of those contracting the disease is already so much higher than that. If you are less than 70 years old you have a 99.5% chance of survival, if you are less than 50 years old you have a 99.98% chance of survival, and if you are less than 20 years old, you have a 99.997% chance of survival. Notably, the vaccine trials had too few positive cases to assess with statistical significance any benefit in secondary outcomes such as decreased mortality or hospitalization. (ref: https://www.bmj.com/content/371/bmj.m4037) 3. The Vaccine Lasts Unknown Duration. We know very little about the longevity of the immunity acquired for COVID-19 from natural infections or from the vaccines. Will the vaccination give long lasting immunity or will another vaccination be needed next year? Recent studies have shown that the body’s immune response to the virus, as measured in levels of antibodies and T-cells, tends to wane over time. “We don’t know how long immunity lasts,” said Akiko Iwasaki, professor of immunobiology at Yale University. We have no lasting immunity from influenza, for example, because the virus is constantly mutating, we are required to get a new shot each year. Pharmaceutical companies and researchers guess that the COVID-19 vaccine should be annual, but with little scientific basis for this timeline. V. COVID-19 Experimental Vaccines Precise language is an important way to combat disinformation. There are no COVID-19 vaccines. The correct terminology is that there are experimental COVID-19 vaccines, also known as investigational COVID-19 vaccines. Multiple types of vaccines are being tried; here is an overview of the categories. The ones closest to mass distribution are the mRNA vaccines.33 One reason we must call this what it is, which is experimental, is because the American public has been primed to receive this biological agent simply because the word experimental has gone missing. Almost no normal person would volunteer to be the first to receive an experimental drug unless they were very sick and there were no alternatives. With COVID-19 the vast majority of people do not get very sick, and there are many alternative treatments. We must insist on using the correct language of experimental vaccine. The other reason we must call this what it is, experimental, is because having an experimental status has important legal implications. These agents are being distributed under an EUA (emergency use authorization)34 which determines how future harm to patients will be compensated. 33 https://www.nature.com/articles/d41586-020-01221-y 34https://www.fda.gov/media/144245/download?utm_campaign=The%20DC%20Today&utm_medium= email&_hsmi=102466647&_hsenc=p2ANqtz--L3Cb8fl6aCL4ZBDWT3lZC_zZIxF7sEiXXY- 18 Note the language the Pharmaceutical company uses in its December 10, 2020 Advisory Report to the FDA. We must use the same language but not all Americans know or understand the word “investigational.”

That should be enough to get anyone thinking … I hope.